This study utilized 10 unique key pathways and 5 common key pathways along with their associated targets to develop key pathway-target networks, aiming to explore the core targets that underpin the similarities and differences between ACP and anti-allergic drugs in treating allergic diseases. This evidence concerns the gene NDUFAB1 and allergic disease.